---
title: Multi-Objective Coverage via Constraint Active Search
title_zh: 基于约束主动搜索的多目标覆盖
authors: "Zakaria Shams Siam, Xuefeng Liu, Chong Liu"
date: 2026-02-17
pdf: "https://arxiv.org/pdf/2602.15595v1"
tags: ["query:sr"]
score: 6.0
evidence: 加速药物和材料设计中的科学发现
tldr: 本研究针对药物发现等领域提出了多目标覆盖（MOC）问题，旨在寻找能广泛覆盖可行多目标空间的代表性样本集。由于现有方法多关注样本空间覆盖或帕累托前沿，难以处理目标空间约束，作者提出了MOC-CAS算法。该算法结合高斯过程后验预测与置信上限采集函数，并通过平滑松弛技术优化硬可行性测试。实验证明，该方法在新冠病毒及癌症蛋白质靶点数据集上表现优异，显著提升了科学发现的效率。
motivation: 现有的多目标优化方法主要关注帕累托前沿，忽略了在满足安全约束的前提下对整个目标空间的代表性覆盖。
method: 提出MOC-CAS算法，利用高斯过程建模并结合置信上限采集函数，同时引入平滑松弛技术以实现高效的约束优化。
result: 在SARS-CoV-2和癌症相关的大规模蛋白质靶点数据集上，该方法在五个目标的覆盖性能上均显著优于竞争基准。
conclusion: MOC-CAS为受限多目标空间下的样本发现提供了高效方案，能显著加速药物研发和材料设计等科学探索过程。
---

## 摘要
在本文中，我们提出了一个新的多目标覆盖（MOC）问题，其目标是识别一小组代表性样本，这些样本的预测结果能广泛覆盖可行的多目标空间。这一问题在许多关键的现实应用中具有重要意义，例如药物发现和材料设计，因为评估这一代表性集合的速度远快于评估整个可行集，从而显著加速了科学发现过程。现有的工作无法直接应用，因为它们要么侧重于样本空间覆盖，要么侧重于针对帕累托前沿（Pareto front）的多目标优化。然而，化学性质多样的样本往往会产生相同的目标特征，且安全约束通常定义在目标上。为了解决这一 MOC 问题，我们提出了一种新型搜索算法 MOC-CAS，该算法采用基于置信上限（UCB）的采集函数，在高斯过程（Gaussian process）后验预测的指导下选择乐观样本。为了实现高效优化，我们开发了硬可行性测试的光滑松弛版本，并推导出了一个近似优化器。与具有竞争力的基准模型相比，实验结果表明我们的 MOC-CAS 在 SARS-CoV-2 和癌症的大规模蛋白质靶点数据集上均取得了优越的性能，每个数据集都基于 SMILES 特征衍生的五个目标进行评估。

## Abstract
In this paper, we formulate the new multi-objective coverage (MOC) problem where our goal is to identify a small set of representative samples whose predicted outcomes broadly cover the feasible multi-objective space. This problem is of great importance in many critical real-world applications, e.g., drug discovery and materials design, as this representative set can be evaluated much faster than the whole feasible set, thus significantly accelerating the scientific discovery process. Existing works cannot be directly applied as they either focus on sample space coverage or multi-objective optimization that targets the Pareto front. However, chemically diverse samples often yield identical objective profiles, and safety constraints are usually defined on the objectives. To solve this MOC problem, we propose a novel search algorithm, MOC-CAS, which employs an upper confidence bound-based acquisition function to select optimistic samples guided by Gaussian process posterior predictions. For enabling efficient optimization, we develop a smoothed relaxation of the hard feasibility test and derive an approximate optimizer. Compared to the competitive baselines, we show that our MOC-CAS empirically achieves superior performances across large-scale protein-target datasets for SARS-CoV-2 and cancer, each assessed on five objectives derived from SMILES-based features.